STOCKHOLM (AP) — A cell biologist was awarded the Nobel Prize in medicine on Monday for his discoveries about the immune system but hours later his university said that he had been dead for three days.
The Nobel committee had been unaware of Canadian-born Ralph Steinman's death and it was unclear whether the prize would be rescinded because Nobel statutes don't allow posthumous awards.
Steinman, 68, who shared the 10 million kronor ($1.5 million) prize with American Bruce Beutler and French scientist Jules Hoffmann, died on Sept. 30 of pancreatic cancer, according to Rockefeller University. It said Steinman's life had been extended with immunotherapy based on the discovery for which he won the Nobel Prize.
In the 1970s, Steinman found dendritic cells that help regulate adaptive immunity, an immune system response that purges invading microorganisms from the body.
Beutler and Hoffmann were cited for their discoveries in the 1990s of receptor proteins that can recognize bacteria and other microorganisms as they enter the body, and activate the first line of defense in the immune system, known as innate immunity.
"I am very touched. I'm thinking of all the people who worked with me, who gave everything," Hoffmann said by telephone to a news conference in Paris. "I wasn't sure this domain merited a Nobel."
The trio's discoveries have enabled the development of improved vaccines against infectious diseases. In the long term they could also yield better treatments of cancer, rheumatoid arthritis, type 1 diabetes, multiple sclerosis, and chronic inflammatory diseases, prize committee members said.
Since 1974, the Nobel statutes don't allow posthumous awards unless a laureate dies after the announcement but before the Dec. 10 award ceremony. That happened in 1996 when economics winner William Vickrey died a few days after the announcement.
Nobel officials said they believed it was the first time that a laureate had died before the announcement without the committee's knowledge.
"I think you can safely say that this hasn't happened before," Nobel Foundation spokeswoman Annika Pontikis told the AP.
Before the statues were changed in 1974 two Nobel Prizes were given posthumously. In 1961 U.N. Secretary General Dag Hammarskjold was awarded the Nobel Peace Prize less than a month after he died in a plane crash during a peace mission to Congo. Swedish poet Erik Axel Karlfeldt won the Nobel Prize in literature in 1931, although he had died in March the same year.
Nobel committee member Goran Hansson said the medicine committee didn't know Steinman was dead when it chose him as a winner and was looking through its regulations.
"It is incredibly sad news," Hansson said. "We can only regret that he didn't have the chance to receive the news he had won the Nobel Prize. Our thoughts are now with his family."
The discoveries have helped scientists understand why the immune system sometimes attacks its own tissues, paving the way for new ways to fight inflammatory diseases.
"They have made possible the development of new methods for preventing and treating disease, for instance with improved vaccines against infections and in attempts to stimulate the immune system to attack tumors," the committee said.
No vaccines are on the market yet, but Hansson told The Associated Press that vaccines against hepatitis are in the pipeline.
"Large clinical trials are being done today," he said.
Beutler, 53, is professor of genetics and immunology at The Scripps Research Institute in San Diego, California. Hoffmann, 70, headed a research laboratory in Strasbourg, France, between 1974 and 2009 and served as president of the French National Academy of Sciences between 2007-2008.
Steinman had been affiliated with Rockefeller University in New York since 1970, and headed its Center for Immunology and Immune Diseases.
"We are all so touched that our father's many years of hard work are being recognized with a Nobel Prize," Steinman's daughter, Alexis Steinman, said in the Rockefeller University statement. "He devoted his life to his work and his family, and he would be truly honored."
Hoffmann's discovery came in 1996 during research on how fruit flies fight infections. Two years later, Beutler's research on mice showed that fruit flies and mammals activate innate immunity in similar ways when attacked by germs.
Steinman's discovery dates back to 1973, when he found a new cell type, the dendritic cell, which has a unique capacity to activate so-called T-cells. Those cells have a key role in adaptive immunity, when antibodies and killer cells fight infections. They also develop a memory that helps the immune system mobilize its defenses next time it comes under a similar attack.
The medicine award kicked off a week of Nobel Prize announcements, and will be followed by the physics prize on Tuesday, chemistry on Wednesday, literature on Thursday and the Nobel Peace Prize on Friday. The winners of the economics award will be announced on Oct. 10.
The coveted prizes were established by wealthy Swedish industrialist Alfred Nobel — the inventor of dynamite — except for the economics award, which was created by Sweden's central bank in 1968 in Nobel's memory. The prizes are always handed out on Dec. 10, on the anniversary of Nobel's death in 1896.
Last year's medicine award went to British professor Robert Edwards for fertility research that led to the first test tube baby.
Associated Press writer Malin Rising contributed to this report.
Berita sebelumnya....STOCKHOLM (Reuters) - Three scientists who unlocked secrets of the body's immune system, opening doors to new vaccines and treatments for cancer, won the 2011 Nobel prize for medicine on Monday.
American Bruce Beutler and French biologist Jules Hoffmann, who studied the first stages of immune responses to attack, shared the $1.5 million award with Canadian-born Ralph Steinman, working in the United States, who discovery of dendritic cells key to understanding the later stages.
"This year's Nobel laureates have revolutionised our understanding of the immune system by discovering key principles for its activation," the award panel at Sweden's Karolinska Institute said in a statement in Stockholm.
Lars Klareskog, who chairs the prize-giving Nobel Assembly, told Reuters: "I am very excited about what these discoveries mean. I think that we will have new, better vaccines against microbes and that is very much needed now with the increased resistance against antibiotics.
"I also expect that there will be some development in the area of attacking cancers from the self-immune system. There are some promising things there."
Annika Scheynius, a professor of clinical allergy research and a member of the panel, said: "We are definitely sure that these discoveries will lead to health improvement ... They can improve the health of patients with cancer, inflammatory diseases, auto-immune diseases, asthma."
Beutler, 53, is based at the Scripps Research Institute in La Jolla, California. Luxembourg-born Hoffmann, 70, conducted much of his work in Strasbourg. They will share half the 10 million Swedish crowns ($1.46 million) of prize-money. The rest goes to Steinman, 68, from Rockefeller University in New York.
The work of the three scientists has been pivotal to the development of improved types of vaccines against infectious diseases and novel approaches to fighting cancer. The research has helped lay the foundations for a new wave of "therapeutic vaccines" that stimulate the immune system to attack tumours.
Better understanding of the complexities of the immune system has also given clues for treating inflammatory diseases, such as rheumatoid arthritis, where the components of the self-defence system end up attacking the body's own tissues.
Medicine, or physiology, is usually the first of the Nobel prizes awarded each year. Prizes for achievements in science, literature and peace were first awarded in 1901 accordance with the will of dynamite inventor and businessman Alfred Nobel.
The award citation noted that the world's scientists had long been searching for the "gatekeepers" of the immune response by which man and other animals defend themselves against attack by bacteria and other micro-organisms.
Beutler and Hoffmann discovered receptor proteins that can recognise attacking microorganisms and which activate "innate immunity", the first step in the body's immune response.
"Ralph Steinman discovered the dendritic cells of the immune system and their unique capacity to activate and regulate adaptive immunity, the later stage of the immune response during which microorganisms are cleared from the body," it added.
Hoffmann's pioneering research was actually conducted on fruit flies, highlighting how key elements of modern human biology have been conserved through evolution.
The immune system exists primarily to protect against infections but it can also protect against some cancers by targeting rogue cells before they proliferate.
Sometimes, however, the immune system goes into overdrive and attacks healthy tissue, leading to autoimmune inflammatory diseases, such as type 1 diabetes and multiple sclerosis, as well as rheumatoid arthritis. The effect is often compared to "friendly fire", when troops hit their own comrades in combat.
($1 = 6.868 Swedish Crowns)
(Additional reporting by Ben Hirschler in London and Mia Shanley in Stockholm; Writing by Alastair Macdonald)